Use of Intravenous Furosemide to Prevent Febrile UTI Following Flexible Ureterorenoscopic Laser Lithotripsy

  • Robin Bahadur Basnet National Academy of Medical Sciences, Kathmandu, Nepal
  • Sanjay Bikram Shrestha Nepal Police Hospital, Kathmandu, Nepal
  • Jitendra Shrestha Nepal Police Hospital, Kathmandu, Nepal
  • Bipin Shrestha Nepal Police Hospital, Kathmandu, Nepal
Keywords: flexible ureterorensocopy, furosemide, laser lithotripsy, urinary tract infection

Abstract

Introduction: Flexible ureterorenoscopic laser lithotripsy is the preferred management option for renal stones less than 2 cm. However, flexible ureterorenoscopic laser lithotripsy is not without complications and urinary tract infection is the most common reported complication. Prophylactic antibiotic use, access sheath, low pressure irrigation are few methods to reduce incidence of urinary tract infection. We have studied whether routine use of intravenous furosemide reduces the incidence of febrile urinary tract infection.

Methods: A total of 70 patients were randomized into two groups where one received intravenous furosemide at the beginning of the procedure and another did not. Flexible ureteroscopic holmium laser lithotripsy was done and patients were followed up for development of febrile urinary tract infection within one week of the procedure.

Results: 14% of patients who received furosemide and 20% of patients who did not receive developed post- operative febrile urinary tract infection within one week. Two patients in each group had bacteriuria.

Conclusions: Although the incidence of febrile UTI is lesser with routine use of intravenous furosemide during flexible ureterorensocopic laser lithotripsy, statistical significance could not be proved.

Published
2019-12-17
Section
ORIGINAL ARTICLE